Efficacy and Safety of Disitamab Vedotin Combined with Gemcitabine as Neoadjuvant Therapy in Muscle-invasive Bladder Cancer: An Open-label, Multicenter, Single-arm, Phase 2 Trial
作者
Hai Huang,Wei Ma,Xing Zeng,Li Jiang,Haitao Dai,Gaofeng Zhou,Jie Wan,Yucong Zhang,Zhiquan Hu,Chunguang Yang